Article info
PDFTherapeutics
Losartan reduced cardiovascular morbidity and mortality more than atenolol in patients with diabetes and essential hypertension
Citation
Losartan reduced cardiovascular morbidity and mortality more than atenolol in patients with diabetes and essential hypertension
Publication history
- First published November 1, 2002.
Online issue publication
November 01, 2002
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 by the ACP-ASIM and BMJ Publishing Group for Evidence-Based Medicine and by the ACP-ASIM for portions reproduced from ACP Journal Club